Renal Division, Brigham and Women's Hospital, Boston, MA, USA.
Crit Care Med. 2011 Apr;39(4):671-7. doi: 10.1097/CCM.0b013e318206ccdf.
We hypothesized that deficiency in 25-hydroxyvitamin D before hospital admission would be associated with all-cause mortality in the critically ill.
Multicenter observational study of patients treated in medical and surgical intensive care units.
A total of 209 medical and surgical intensive care beds in two teaching hospitals in Boston, MA.
A total of 2399 patients, age ≥ 18 yrs, in whom 25-hydroxyvitamin D was measured before hospitalization between 1998 and 2009.
None.
Preadmission 25-hydroxyvitamin D was categorized as deficiency in 25-hydroxyvitamin D (≤ 15 ng/mL), insufficiency (16-29 ng/mL), and sufficiency (≥ 30 ng/mL). Logistic regression examined death by days 30, 90, and 365 post-intensive care unit admission, in-hospital mortality, and blood culture positivity. Adjusted odds ratios were estimated by multivariable logistic regression models. Preadmission 25-hydroxyvitamin D deficiency is predictive for short-term and long-term mortality. At 30 days following intensive care unit admission, patients with 25-hydroxyvitamin D deficiency have an odds ratio for mortality of 1.69 (95% confidence interval of 1.28-2.23, p < .0001) relative to patients with 25-hydroxyvitamin D sufficiency. 25-Hydroxyvitamin D deficiency remains a significant predictor of mortality at 30 days following intensive care unit admission following multivariable adjustment (adjusted odds ratio of 1.69, 95% confidence interval of 1.26-2.26, p < .0001). At 30 days following intensive care unit admission, patients with 25-hydroxyvitamin D insufficiency have an odds ratio of 1.32 (95% confidence interval of 1.02-1.72, p = .036) and an adjusted odds ratio of 1.36 (95% confidence interval of 1.03-1.79, p = .029) relative to patients with 25-hydroxyvitamin D sufficiency. Results were similar at 90 and 365 days following intensive care unit admission and for in-hospital mortality. In a subgroup analysis of patients who had blood cultures drawn (n = 1160), 25-hydroxyvitamin D deficiency was associated with increased risk of blood culture positivity. Patients with 25-hydroxyvitamin D insufficiency have an odds ratio for blood culture positivity of 1.64 (95% confidence interval of 1.05-2.55, p = .03) relative to patients with 25-hydroxyvitamin D sufficiency, which remains significant following multivariable adjustment (odds ratio of 1.58, 95% confidence interval of 1.01-2.49, p = .048).
Deficiency of 25-hydroxyvitamin D before hospital admission is a significant predictor of short- and long-term all-cause patient mortality and blood culture positivity in a critically ill patient population.
我们假设入院前 25-羟维生素 D 缺乏与危重症患者的全因死亡率有关。
对在马萨诸塞州波士顿的两家教学医院的内科和外科重症监护病房接受治疗的患者进行的多中心观察性研究。
共有 209 张内科和外科重症监护病床。
2009 年期间入院前测量了 25-羟维生素 D 的共 2399 名年龄≥18 岁的患者。
无。
入院前 25-羟维生素 D 分为 25-羟维生素 D 缺乏(≤15ng/ml)、不足(16-29ng/ml)和充足(≥30ng/ml)。使用逻辑回归分析重症监护病房入院后 30 天、90 天和 365 天的死亡率、院内死亡率和血培养阳性率。使用多变量逻辑回归模型估计校正后比值比。入院前 25-羟维生素 D 缺乏是短期和长期死亡率的预测因素。在重症监护病房入院后 30 天,与 25-羟维生素 D 充足的患者相比,25-羟维生素 D 缺乏的患者死亡的比值比为 1.69(95%置信区间为 1.28-2.23,p<.0001)。在校正多变量后,25-羟维生素 D 缺乏仍然是重症监护病房入院后 30 天死亡率的显著预测因素(校正比值比为 1.69,95%置信区间为 1.26-2.26,p<.0001)。在重症监护病房入院后 30 天,与 25-羟维生素 D 充足的患者相比,25-羟维生素 D 不足的患者的比值比为 1.32(95%置信区间为 1.02-1.72,p=0.036)和校正比值比为 1.36(95%置信区间为 1.03-1.79,p=0.029)。在重症监护病房入院后 90 天和 365 天以及院内死亡率的结果相似。在对接受血培养的患者(n=1160)的亚组分析中,25-羟维生素 D 缺乏与血培养阳性风险增加相关。与 25-羟维生素 D 充足的患者相比,25-羟维生素 D 不足的患者血培养阳性的比值比为 1.64(95%置信区间为 1.05-2.55,p=0.03),在校正多变量后仍然显著(比值比为 1.58,95%置信区间为 1.01-2.49,p=0.048)。
入院前 25-羟维生素 D 缺乏是危重症患者短期和长期全因死亡率以及血培养阳性的显著预测因素。